In recent years, men’s health has shifted from being a quiet, private matter to an open conversation fueled by technology and ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...

Stock index futures rose on Friday, with Dow futures leading the charge, as UnitedHealth got a boost after Berkshire Hathaway ...

A spokesperson for Hims did not immediately respond to a request for comment. The company previously said it was cooperating ...

Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...

Investors with substantial losses have the opportunity (until August 25, 2025) to move the court for appointment as Lead Plaintiff. Shareholder rights firm Hagens Berman is investigating the legal ...

HIMS investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

The summary covers recent significant developments in health news including Warren Buffett's Berkshire Hathaway's investment in UnitedHealth Group and the struggles of the UK's bioethanol industry due ...

Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg report that revealed the Federal Trade Commission has been investigating the telehealth ...